3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
4
Stomach Neoplasms
3
Uterine Cervical Neoplasms
1
Smoking
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Platelet Glycoprotein IV Deficiency
1
Pediatric Brain Tumor
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Locally Advanced Pancreatic Cancer
1
Gastrointestinal Neoplasms
1
Fatty Liver
1
Cysts
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
115
Carboplatin
103
Pemetrexed
90
Cisplatin
58
Paclitaxel
47
osimertinib
41
Drug Therapy
40
Nivolumab
39
Docetaxel
35
Specimen Handling
33
Magnetic Resonance Spectroscopy
28
Bevacizumab
26
durvalumab
23
Gemcitabine
22
cemiplimab
21
Radiotherapy
20
130-nm albumin-bound paclitaxel
20
Radiosurgery
19
tislelizumab
18
atezolizumab
17
aflutinib
15
Cetuximab
15
Immunotherapy
14
Immune Checkpoint Inhibitors
14
Platinum Compounds
13
Ipilimumab
13
Biopsy
12
Standard of Care
11
Surgical Procedures, Operative
10
Injections
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Non-Small-Cell Lung
×
Tomography, X-Ray Computed
×
Clear all
NCT06082492
2025-02-05
NVALT31-PET
Radboud University Medical Center
Phase NA
Recruiting
690 enrolled